Gink­go sells Zymer­gen lab to chem­i­cal and ma­te­r­i­al man­u­fac­tur­er Solvay

Gink­go Bioworks is sell­ing a lab ac­quired through last year’s $300 mil­lion ac­qui­si­tion of Zymer­gen to the multi­na­tion­al chem­i­cal and ma­te­ri­als com­pa­ny Solvay, part of what the com­pa­nies are de­scrib­ing as a strate­gic col­lab­o­ra­tion.

The com­pa­nies put word out Tues­day morn­ing that they’ll part­ner in a mul­ti-year deal on man­u­fac­tur­ing sus­tain­able ma­te­ri­als, in­clud­ing biopoly­mers with non-med­ical us­es. Both com­pa­nies de­clined to talk about the fi­nan­cials of the deal, but Gink­go said that Solvay paid an undis­closed amount to Zymer­gen for the build­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER